About the ANCA-Associated Vasculitis Working Group
The methods for creating a composite outcome are different than for individual domain-directed outcomes and this Workshop will help attendees understand the steps required for this process through a project that is funded by ACR and EULAR to create response criteria for ANCA-associated vasculitis for use in clinical trials. Attendees are encouraged before the Workshop to view the short but highly informative videos developed to inform everyone on the disease under study and the methods employed for this project.
Haner Direskeneli
Co-Chair
Sarah Mackie
Co-Chair
Peter Merkel
Co-Chair
Gunnar Tómasson
Co-Chair
Kaitlin Quinn
Fellow
Sara Monti
Fellow
Georgia Lanier
Patient Research Partner
Introduction to Antineutrophil cytoplasmic antibody ANCA-Associated Vasculitis
Introduction To Methodology To Develop A Composite Outcome Measure For ANCA-Associated Vasculitis
OMERACT Endorsed Core Domain Set for Clinical Trials in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Working Group Members:
Alexa Meara
Beverley Shea
Carol Langford
Cristina Ponte
Georgia Lanier
Gulen Hatemi
Gunnar Tomasson
Haner Direskeneli
Kaitlin Quinn
Nataliya Milman
Peter Merkel
Peter Tugwell
Sara Monti
Sarah Mackie
Tanaz Kermani
Yesim Ozguler
Peter Grayson